title: Critical role of the March of Dimes in the expansion of newborn screening.
abstract: Expansion of newborn screening (NBS) has been driven primarily by a combination of advances in technology and medical treatment, and the sustained advocacy efforts of consumers and voluntary health organizations. The longstanding leadership of the March of Dimes has been credited by many as a critical factor in the expansion and improvement of state NBS programs. From the historic vantage point of four decades of March of Dimes involvement with newborn screening, this report reviews the unique origin of the first newborn screening test, and identifies from this point of origin several of the elements which still define the evolution of advocacy for NBS today. It also documents activities at the federal level and in seven states that have lead to expanded screening for newborns. Advances in NBS technology and medical treatment have informed policy development. Mobilization of volunteers and focused advocacy activities have brought about expansion of screening opportunities for newborns across the United States. But more work is needed. Continued application of the effective strategies identified in this report will help assure that all families have the best possible chance of assuring that their newborns do not have to suffer the complications of conditions that we know can be treated effectively.
authors.affiliation: March of Dimes, 1275 Mamaroneck Avenue, White Plains, New York 10607, USA.
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Howse
authors.forename: Marina
authors.initials: M
authors.lastname: Weiss
authors.forename: Nancy S
authors.initials: NS
authors.lastname: Green
mesh_terms: D005380:Financing, Government / Q000331:legislation & jurisprudence; D005544:Forecasting; D006301:Health Services Needs and Demand / Q000191:economics / Q000639:trends; D006801:Humans; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000209:etiology / Q000517:prevention & control*; D015997:Neonatal Screening / Q000331:legislation & jurisprudence / Q000639:trends*; D010661:Phenylketonurias / Q000175:diagnosis; D012015:Reference Standards; D053719:Tandem Mass Spectrometry; D014481:United States; D014837:Voluntary Health Agencies / Q000331:legislation & jurisprudence / Q000639:trends*